SCHEMBL18739757

SCHEMBL18739757

Cc1cnc(-c2c[nH]c3ncc(Cl)cc23)nc1N[C@H]1CCCC[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10304335 0.89 — —
SCHEMBL21014898 0.89 — —
SCHEMBL18629412 0.89 — —
SCHEMBL10007203 0.89 CDC7 (0.44) —
SCHEMBL10304332 0.87 — —
SCHEMBL16015244 0.85 — —
SCHEMBL10304354 0.82 — —
SCHEMBL10304242 0.81 CDC7 (0.47) —
SCHEMBL18629031 0.81 — —
SCHEMBL10007187 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9808459-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-11-07 — — US disclosed
US-20170100400-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED 2017-04-13 — — US disclosed
Send feedback